ValerieReneeSuskiDO

Neurology • Pittsburgh, PA

Assistant Professor, Neurology, University of Pittsburgh School of Medicine

Join to view full profile

Dr. Suski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Suski's full profile

Already have an account?

Office
3471 5th Ave
Ste 811
Pittsburgh, PA 15213
Phone+1 412-692-4600

Fax+1 412-692-4907

Education & Training

Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2006 - 2007
Virginia Commonwealth University Health SystemResidency, Neurology, 2003 - 2006
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2002 - 2003
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2002

Certifications & Licensure

PA State License 2007 - 2026
VA State License 2002 - 2006
American Board of Psychiatry and Neurology Neurology

Clinical Trials

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease Start of enrollment: 2007 Jul 01
Completed
Phase 2
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Terminated
Phase 3
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease Start of enrollment: 2011 Mar 24
Completed
Phase 2
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease Start of enrollment: 2014 Feb 28
Completed
Phase 2
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease Start of enrollment: 2016 May 10
Completed
Phase 2
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Start of enrollment: 2016 Feb 11
Completed
Phase 4
Development of the Virtual Unified Huntington's Disease Rating Scale Start of enrollment: 2022 Sep 22
Completed
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

7 citations
Differential tractography as a dynamic imaging biomarker: A methodological pilot study for Huntington's disease.
Jessica V Barrios-Martinez, David T Fernandes-Cabral, Kumar Abhinav, Juan C Fernandez-Miranda, Yue-Fang Chang
Neuroimage. Clinical. 2022-01-01
92 citations
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
Michael A. Schwarzschild, Alberto Ascherio, Cindy Casaceli, Gary C. Curhan, Rebecca Fitzgerald
JAMA. 2021-09-14
15 citations
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach
Journal of Clinical Medicine. 2020-11-16

Professional Memberships

Other Languages

Spanish